Diabetic macular edema Trials in Charlotte, United States
Conditions / Diabetic macular edema / Charlotte, United States
Research into Diabetic macular edema spans multiple therapeutic approaches and trial phases.
29 total trials for this combination
Showing top 10 of 29 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04108156 | A Study to Evaluate Efficacy, Safety & Pharmacokinetics of the Port Delivery System (PDS) With Ranibizumab in Participants With Diabetic Macular Edema (DME) Compared With Intravitreal Ranibizumab; A Substudy to Evaluate the Safety of Re-implanting the PDS With Ranibizumab in Participants With DME | RECRUITING | PHASE3 |
| NCT03345901 | PROMINENT-Eye Ancillary Study (Protocol AD) | TERMINATED | PHASE3 |
| NCT03622580 | A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE) | COMPLETED | PHASE3 |
| NCT04432831 | A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Diabetic Macular Edema | COMPLETED | PHASE3 |
| NCT01909791 | Treatment for CI-DME in Eyes With Very Good VA Study | COMPLETED | PHASE3 |
| NCT00367133 | Intravitreal Triamcinolone Acetonide Versus Laser for Diabetic Macular Edema | COMPLETED | PHASE3 |
| NCT00444600 | Laser-Ranibizumab-Triamcinolone for Diabetic Macular Edema | COMPLETED | PHASE3 |
| NCT01627249 | Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema | COMPLETED | PHASE3 |
| NCT04429503 | Study of a High-Dose Aflibercept in Participants With Diabetic Eye Disease | COMPLETED | PHASE2/PHASE3 |
| NCT02634333 | Anti-VEGF Treatment for Prevention of PDR/DME | COMPLETED | PHASE3 |